Cancer signaling, cell/gene therapy, diagnosis and role of nanobiomaterials

Author:

,Rosic Gvozden

Abstract

An important characteristic of cancer is aberrant metabolism. Drug resistance, cancer stem cells, metastasis and tumorigenesis are all significantly impacted by abnormal cancer metabolism, which includes enhanced anabolic pathways and aerobic glycolysis. The Hippo pathway, Myc and PI3K/AKT are recognized oncogenic signaling networks that control the expression of metabolic genes and increase the level of activity of metabolic enzymes. On the other hand, abnormal metabolic pathways result in disruptions to the internal signal transduction pathways of cells, providing energy, building blocks and redox capabilities necessary for uncontrolled cancer cell proliferation. Studies and clinical trials are being carried out to investigate the impact of minute substances or dietary modifications, such as calorie restriction, fasting and intermittent fasting, on the inhibition of metabolic enzymes. The metabolic phenotypes of malignancies are remarkably diverse, much like genetic variability. Genetic abnormalities and a variety of signals found in the tumor microenvironment contribute to this variability. Therefore, one of the main objectives of contemporary cancer therapies is to overcome metabolic plasticity. This overview explains the relationships between biochemical and pathways of signaling and emphasizes recent research on the metabolic properties of cancer. We also present fresh justifications for the upcoming class of medications that target cancer metabolism. This is an overview of our latest studies on the progress of nanomedicine and disease detection at the tiny level of nano-bio interactions between biological systems and nanoparticles. Significant progress in the field of nanomedicine has been accomplished in the last 20 years. However, the absence of a thorough knowledge of nano-bio interactions in the clinical situation makes it difficult to significantly improve overall patient survival with nanomedicine.

Publisher

Jomard Publishing

Cited by 44 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3